Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Getinge ( ($SE:GETI.B) ).
Getinge will publish its Year-End Report for 2025 on January 27, 2026, and will host a same-day conference call led by President & CEO Mattias Perjos and CFO Agneta Palmér for fund managers, analysts and media. The call, which will be accompanied by a webcast presentation and followed by a three-year-available recording, underscores the company’s efforts to maintain transparency with capital markets and other stakeholders regarding its financial performance and strategic development.
The most recent analyst rating on ($SE:GETI.B) stock is a Hold with a SEK230.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a global medical technology company that supplies hospitals and life science institutions with products and solutions designed to improve clinical outcomes and optimize workflows. Its portfolio spans intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science applications, and the company employs around 12,000 people with sales in 135 countries.
Average Trading Volume: 480,198
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK61.12B
For a thorough assessment of GETI.B stock, go to TipRanks’ Stock Analysis page.